BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29942153)

  • 21. Fertility preservation in males with cancer: 16-year monocentric experience of sperm banking and post-thaw reproductive outcomes.
    Depalo R; Falagario D; Masciandaro P; Nardelli C; Vacca MP; Capuano P; Specchia G; Battaglia M
    Ther Adv Med Oncol; 2016 Nov; 8(6):412-420. PubMed ID: 27800030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel treatment concepts in Hodgkin lymphoma.
    Glimelius I; Diepstra A
    J Intern Med; 2017 Mar; 281(3):247-260. PubMed ID: 27991731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reaserch Advance on Treatment Strategies for Relapsed/Refractory Hodgkin's Lymphoma--Review].
    Jin DC; Zhao L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):343-349. PubMed ID: 32027301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
    Martinez F
    Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphoma.
    Evens AM; Altman JK; Mittal BB; Hou N; Rademaker A; Patton D; Kaminer L; Williams S; Duffey S; Variakojis D; Singhal S; Tallman MS; Mehta J; Winter JN; Gordon LI
    Ann Oncol; 2007 Apr; 18(4):679-88. PubMed ID: 17307757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current strategies and new approaches in the treatment of Hodgkin's lymphoma.
    Fuchs M; Diehl V; Re D
    Pathobiology; 2006; 73(3):126-40. PubMed ID: 17085957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current treatment and immunotherapy of Hodgkin's lymphoma.
    Klimm B; Schnell R; Diehl V; Engert A
    Haematologica; 2005 Dec; 90(12):1680-92. PubMed ID: 16330443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial.
    Younes A; Santoro A; Shipp M; Zinzani PL; Timmerman JM; Ansell S; Armand P; Fanale M; Ratanatharathorn V; Kuruvilla J; Cohen JB; Collins G; Savage KJ; Trneny M; Kato K; Farsaci B; Parker SM; Rodig S; Roemer MG; Ligon AH; Engert A
    Lancet Oncol; 2016 Sep; 17(9):1283-94. PubMed ID: 27451390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refractory or relapsed Hodgkin's disease and non-Hodgkin's lymphoma: optimizing involved-field radiotherapy in transplant patients.
    Kahn ST; Flowers CR; Lechowicz MJ; Hollenbach K; Johnstone PA
    Cancer J; 2005; 11(5):425-31. PubMed ID: 16259874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UK.
    Jackson GH; Wood A; Taylor PR; Lennard AL; Lucraft H; Heppleston A; Robinson P; Moore J; Proctor SJ
    Leuk Lymphoma; 1997 Dec; 28(1-2):127-32. PubMed ID: 9498711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation.
    Taçyıldız N; Tanyıldız HG; Ünal E; Dinçaslan H; Asarcıklı F; Aksoy BA; Vatansever G; Yavuz G
    Turk J Pediatr; 2019; 61(5):671-676. PubMed ID: 32104998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases].
    Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY
    Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous bone marrow transplantation versus chemotherapy in relapsed/refractory non-Hodgkin's lymphoma: estimates of long-term survival from the recent literature.
    Meehan KR; Pritchard RS; Leichter JW; Littenberg B; Welch HG
    Am J Hematol; 1995 Oct; 50(2):116-23. PubMed ID: 7572990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.
    Goodman KA; Riedel E; Serrano V; Gulati S; Moskowitz CH; Yahalom J
    J Clin Oncol; 2008 Nov; 26(32):5240-7. PubMed ID: 18809615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hodgkin's Lymphoma: Choice of Therapy and Late Complications.
    Linch DC; Gosden RG; Tulandi T; Tan SL; Hancock SL
    Hematology Am Soc Hematol Educ Program; 2000; ():205-221. PubMed ID: 11701543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Genadieva-Stavrik S; Boumendil A; Dreger P; Peggs K; Briones J; Corradini P; Bacigalupo A; Socié G; Bonifazi F; Finel H; Velardi A; Potter M; Bruno B; Castagna L; Malladi R; Russell N; Sureda A
    Ann Oncol; 2016 Dec; 27(12):2251-2257. PubMed ID: 28007754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
    Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
    Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage therapy for Hodgkin's lymphoma.
    Quddus F; Armitage JO
    Cancer J; 2009; 15(2):161-3. PubMed ID: 19390313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study.
    Locatelli F; Mauz-Koerholz C; Neville K; Llort A; Beishuizen A; Daw S; Pillon M; Aladjidi N; Klingebiel T; Landman-Parker J; Medina-Sanson A; August K; Sachs J; Hoffman K; Kinley J; Song S; Song G; Zhang S; Suri A; Gore L
    Lancet Haematol; 2018 Oct; 5(10):e450-e461. PubMed ID: 30290902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991.
    Bennett CL; Armitage JL; Armitage GO; Vose JM; Bierman PJ; Armitage JO; Anderson JR
    J Clin Oncol; 1995 Apr; 13(4):969-73. PubMed ID: 7707125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.